Essential Partners’s SpringWorks Therapeutics SWTX Stock Holding History

Essential Partners’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-297	Closed	-$14K	–	2784
2025 Q2	$14K	Buy	+297	New	+$13.2K	0.01%	763

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Essential Partners's SWTX Position: Q3 2025 in Review

Essential Partners sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 297 shares — an estimated $14K sold.

Essential Partners first reported a position in SWTX in Q2 2025 and held it in 1 quarter. The position peaked at $14K in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Essential Partners reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Essential Partners sold 297 SpringWorks Therapeutics shares in Q3 2025, an estimated $14K.
Essential Partners first reported a position in SpringWorks Therapeutics in Q2 2025 and held it in 1 quarter.
Essential Partners's SpringWorks Therapeutics position peaked at $14K in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Essential Partners's 13F filing for Q3 2025, filed 21 May 2026.